Abstract 3936: CDK12 tumor suppressor function and therapeutic targeting in newly developed mouse models of serous ovarian cancer
Jean C. Tien(University of Michigan), Arul M. Chinnaiyan(Howard Hughes Medical Institute), Kathleen R. Cho(University of Michigan), Xuhong Cao(Howard Hughes Medical Institute), Rong Wu(Nanjing Forestry University), Marcin Cieślik(University of Michigan), Rahul Mannan(University of Michigan), Christina Wheeler(University of Michigan), Yu Chang(University of Michigan), Yuping Zhang(University of Michigan), Yuanyuan Qiao(University of Michigan), Shuqin Li(Xuzhou Medical College), Ke Ding(University of Illinois Urbana-Champaign), Yunhui Cheng(University of Michigan), Caleb Cheng(University of Michigan), Lanbo Xiao(University of Michigan), Yali Zhai(University of Michigan), Abigail J. Todd(University of Michigan), Somnath Mahapatra(University of Michigan)
Cited by 1
Related Papers
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k
Activating ESR1 mutations in hormone-resistant metastatic breast cancer
|Nature Genetics|2013|1.2k
Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing
|Nature Genetics|2013|818
Identification of Targetable FGFR Gene Fusions in Diverse Cancers
|Cancer Discovery|2013|737